India Logs 40,120 New Covid Cases, 585 Deaths in 24 hrs | News Room Odisha

India Logs 40,120 New Covid Cases, 585 Deaths in 24 hrs

New Delhi:  India on Friday registered a marginal decline in daily Covid caseload and recorded 40,120 fresh cases in the last 24 hours.

The country had logged 41,195 new infections over the last 24 hours on Thursday, which was the first time in the past seven days that the daily cases again crossed the 40,000-mark.

A total of 585 deaths were also reported in 24 hours, pushing the death toll to 19 to 4,30,254, said the Covid bulletin released by the Ministry of Health and Family Welfare on Friday.

India has achieved the highest recovery rate ever and currently stands at 97.46 per cent.

The active caseload has seen a dip of 2,760 and currently stands at 3,85,227. The active caseloads constitute 1.20 per cent of total cases that is the lowest since March 2020, as per the bulletin released by the health ministry.

As per the data, total 42,295 patients were discharged from the hospitals and health centres in the last 24 hours, taking the total number of cured to 3,13,02,345 to the date in India.

The weekly positivity rate remains below 5 per cent and is currently at 2.13 per cent. The daily positivity rate continues to remain below 3 per cent for 19 continuous days and currently stands at 2.04 per cent.

Meanwhile, India’s Cumulative Covid vaccination coverage has exceeded 52.89 crore (52,89,27,844), as per the 7 p.m. provisional report on Thursday. A total of 57,31,574 doses of vaccines were administered in the last 24 hours, pushing the total vaccination so far at 52,95,82,956, said the bulletin released by the ministry.

27,83,649 vaccine doses were administered as first dose and 4,85,193 vaccine doses given as second dose in the age group 18-44 years. Cumulatively, 18,76,63,555 persons in the age group 18-44 years across 37 states/UTs have received their first dose and a total 1,39,23,085 have received their second dose since the start of Phase-3 of the vaccination drive.

(IANS)

COVID-19